S. Stekhova

Quantitative fluoroestradiol positron emission tomography imaging predicts response to endocrine treatment in breast cancer.

D. Mankoff, H. Linden, R. Livingston, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Tautomerism of azine derivatives. 5. Effect of the heteroatom on the keto-enol tautomerism of β-keto esters of the azine series

S. Stekhova, V. V. Lapachev, V. P. Mamaev, 1981 .

Systematic screening of potential β-cell imaging agents

Å. Lernmark, K. Krohn, I. Sweet, 2004 .

Site-Specific Labeling of Annexin V with F-18 for Apoptosis Imaging

J. Tait, K. Krohn, J. Link, 2008, Bioconjugate chemistry.

Systematic screening of potential beta-cell imaging agents.

Å. Lernmark, K. Krohn, I. Sweet, 2004, Biochemical and biophysical research communications.

Quantitative Imaging of Estrogen Receptor Expression in Breast Cancer with PET and 18F-Fluoroestradiol

David A. Mankoff, Kenneth A. Krohn, Jeanne M. Link, 2008, Journal of Nuclear Medicine.

Tautomerism of azine derivatives. 4. Keto-enol tautomerism of β-keto esters of the azine series

S. Stekhova, V. V. Lapachev, O. A. Zagulyaeva, 1980, Chemistry of Heterocyclic Compounds.

Tautomerism of azine derivatives. 4. Keto-enol tautomerism of β-keto esters of the azine series

S. Stekhova, V. V. Lapachev, O. A. Zagulyaeva, 1980 .

17 O n.m.r. studies of enol and phenol compounds with intramolecular hydrogen bonds

M. A. Fedotov, S. Stekhova, V. V. Lapachev, 1985 .

Factors influencing the uptake of 18F-fluoroestradiol in patients with estrogen receptor positive breast cancer.

D. Mankoff, H. Linden, B. Kurland, 2011, Nuclear medicine and biology.